Finance

Lists
603811:SHA
Zhejiang Cheng Yi Pharmaceutical Co Ltd
CN¥6.70
-0.30%
(-0.020) 1D
Oct 16, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603811...
Open
CN¥6.75
High
CN¥6.89
Low
CN¥6.62
Mkt. cap
3.14B
Avg. vol.
4.43M
Volume
5.13M
Dividend
3.20%
Quarterly dividend
CN¥0.05
Ex-dividend date
Jun 26, 2026
P/E ratio
16.99
52-wk high
CN¥9.69
52-wk low
CN¥6.61
EPS
CN¥0.39
Shares outstanding
119.28M
No. of employees
604
Open
CN¥6.75
High
CN¥6.89
Low
CN¥6.62
Mkt. cap
3.14B
Avg. vol.
4.43M
Volume
5.13M
Dividend
3.20%
Quarterly dividend
CN¥0.05
Ex-dividend date
Jun 26, 2026
P/E ratio
16.99
52-wk high
CN¥9.69
52-wk low
CN¥6.61
EPS
CN¥0.39
Shares outstanding
119.28M
No. of employees
604
News stories
From web sources and news partners
About Zhejiang Cheng Yi Pharmaceutical Co Ltd
CEO-
Employees604
Founded1966
Headquarters-
SectorPharmaceutical industry
Websitechengyipharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
180.36M
215.32M
201.00M
230.80M
Cost of goods sold
39.95M
80.88M
60.39M
70.74M
Cost of revenue
39.95M
80.88M
60.39M
70.74M
Research and development expenses
12.28M
12.53M
12.82M
10.41M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
92.78M
88.61M
78.44M
93.07M
Operating expense
104.85M
107.45M
96.13M
106.54M
Total operating expenses
144.80M
188.32M
156.51M
177.27M
Operating income
35.56M
26.99M
44.48M
53.52M
Other non operating income
-601.21K
576.34K
-31.10K
17.04K
EBT including unusual items
34.42M
59.97M
50.26M
61.47M
EBT excluding unusual items
42.48M
31.93M
48.05M
60.68M
Income tax expense
3.75M
7.11M
5.64M
10.34M
Effective tax rate
10.90%
11.86%
11.22%
16.83%
Other operating expenses
303.02K
6.81M
3.93M
3.45M
Net income
30.30M
52.39M
44.29M
50.58M
Net profit margin
16.80%
24.33%
22.04%
21.91%
Earnings per share
-
-
-
-
Interest and investment income
8.14M
5.05M
3.81M
7.48M
Interest expense
-865.53K
-336.06K
-212.33K
-178.35K
Net interest expenses
7.28M
4.71M
3.60M
7.30M
Depreciation and amortization charges
-
-
-
-
EBITDA
59.20M
50.55M
68.03M
76.70M
Gain or loss from assets sale
111.92K
-21.06M
-
-61.71K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps